News
Plexus Ventures Assists Glenmark Pharmaceuticals to Out-License Ryaltris™ Nasal Spray to Menarini for numerous markets throughout Europe
Philadelphia, Pennsylvania – Plexus Ventures is pleased to announce the successful conclusion of a licensing agreement of behalf of our client, Glenmark Pharmaceuticals. Mr. Michael O’Sullivan, Plexus Ventures’ Managing Partner, stated: “This transaction is an ideal...
Plexus Ventures Assists Glenmark Pharmaceuticals to Divest a CNS Product Portfolio and Commercial Team in Poland to Neuraxpharm
Philadelphia, Pennsylvania – Plexus Ventures is pleased to announce the completion of a divestiture project on behalf of its client, Glenmark Pharmaceuticals Ltd. Plexus Ventures advised Glenmark on the sale of a CNS product portfolio and sales team to Neuraxpharm....
Olessia Kamp Joins Plexus Ventures as Senior Advisor in Germany
Philadelphia, Pennsylvania – Plexus Ventures announces the appointment of Olessia Kamp, based near Frankfurt, as Senior Advisor in Germany. Prior to joining Plexus, Olessia served for nearly 15 years at Berlin-Chemie AG, a subsidiary of Menarini, focusing from German...
Dr. Daniel Sieiro Mosti Joins Plexus Ventures as Scientific Associate for Gene and Cell Therapies
Philadelphia, Pennsylvania – Plexus Ventures announces the appointment of Dr. Daniel Sieiro Mosti as Scientific Associate. Dr. Sieiro is a former research fellow at Harvard Medical School where he focused on the genetic basis of tissue development in health and...
Plexus Ventures advises Cinfa Group in PLG’s “Deal of the Year”
London, England – The Pharmaceutical Licensing Group, whose mission is promote and support excellence in deal making across the healthcare industry, recently awarded Mundipharma International its inaugural “PLG Deal of the Year” for its acquisition of Cinfa Biotech....
Plexus Ventures Appoints Pierfrancesco Maschio as Director for Southern Europe
Philadelphia, Pennsylvania – Plexus Ventures announces the appointment of Pierfrancesco Maschio, based in Milan, as Director for Southern Europe. Pierfrancesco is a long-time entrepreneur who has successfully built his Ricerchimica healthcare business development...
Mindpax engages Plexus Ventures as Exclusive Advisor to Partner its Digital Platform for Severe Mental Illnesses
Philadelphia and Prague – Mindpax, the innovative digital therapeutics company focused on improving the lives of people with Severe Mental Illnesses (SMIs), has engaged Plexus Ventures as its contract business development organization to identify partners for further...
Plexus Ventures’ Important Company Announcement
Philadelphia, Pennsylvania – Plexus Ventures, a prominent corporate and business development boutique for healthcare companies, is pleased to announce our newest Managing Director. The Partners at Plexus Ventures are very pleased to announce that Ahmed Al-Derzi has...
Articles
Nucleic acid delivery: Are you developing what Big Pharma seeks?
Apr 11, 2023
How can we help you?
Plexus Ventures assists with M&A, divestments, licensing, strategic advice and consulting.
Subscribe to
Plexus News
Follow Us
Check out Plexus Ventures and other industry news shared daily.